BD to Present at Cowen 43rd Annual Healthcare Conference

Rhea-AI Summary

BD (Becton, Dickinson and Company), a top medical technology firm, will present at the Cowen 43rd Annual Healthcare Conference on March 6, 2023, at 9:50 AM Eastern Time. Investors can access the live webcast on BD's investor relations website. A replay will be available after the event. BD focuses on advancing healthcare with innovative technologies and services, supporting healthcare professionals in improving patient outcomes. With a global workforce of 77,000, BD addresses key health challenges through collaborations worldwide. For more details, visit bd.com.

News Market Reaction – BDX

+0.38%

+0.38% Session move

In the trading session that priced this news, BDX gained 0.38%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Cowen 43^rd Annual Healthcare Conference on Monday, March 6, 2023 at 9:50 am Eastern Time.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo. 

Contacts:

Media:	Investors:
Troy Kirkpatrick	Francesca DeMartino
VP, Public Relations	SVP, Head of Investor Relations
858.617.2361	201.847.5743
troy.kirkpatrick@bd.com	francesca.demartino@bd.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-to-present-at-cowen-43rd-annual-healthcare-conference-301752147.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will BD present at the Cowen 43rd Annual Healthcare Conference?

BD will present on March 6, 2023, at 9:50 AM Eastern Time.

How can I access the live webcast of BD's presentation?

The live webcast can be accessed from BD's investor relations website.

Where can I find the replay of BD's presentation?

A replay of the presentation will be available on the BD investor relations website after the event.

What is BD's focus in the healthcare industry?

BD is focused on advancing healthcare through innovative technologies, improving diagnostics, and enhancing patient care.

How many employees does BD have?

BD has approximately 77,000 employees supporting healthcare advancements globally.

What stock symbol does BD operate under?

BD operates under the stock symbol BDX on the NYSE.